Sumary of Self-correcting genetic mutations may protect patients with shortened telomeres from blood cancers:
- People with rare disorders that cause shortened telomeres — protective caps that sit at the end of chromosomes — may be more likely to have blood cancers such as leukemia or myelodyplastic syndrome.
- Now, Johns Hopkins Medicine scientists have discovered several “self-correcting” genetic mutations in bone marrow that may protect such patients from these cancers.
- In a study published online August 3, 2021, in the Journal of Clinical Investigation, the researchers also suggest these mutations can serve as biomarkers that may indicate if patients with short telomere syndromes are likely to develop blood cancers.
- “These are the most common cancers we see in patients with short telomere syndromes,” says Mary Armanios, M.
- , director of the Telomere Center and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- “We know that at a certain point, the cells of patients with shortened telomeres either become cancerous or stay healthy.
- It turns out that the self-correcting mechanism they discovered instead protects cells from becoming cancerous.
- Related StoriesThe researchers tested the bone marrow and blood cells of 84 study participants divided into three groups: those with short telomere syndromes and myelodyplastic syndromes or leukemia;